Orforglipron Intermediate Supplier Europe & UK

High-Purity Orforglipron Intermediates: Direct Manufacturing Partner for UK & Europe

The authorization of Orforglipron (Foundayo™) by the UK Medicines and Healthcare products Regulatory Agency (MHRA) in August 2026 marked a historic turning point in the European pharmaceutical market. As the world’s first oral, non-peptide small-molecule GLP-1 receptor agonist authorized for obesity management and type 2 diabetes, Orforglipron eliminates the cold-chain storage and fasting dosing restrictions associated with peptide therapies.

Because Orforglipron (CAS: 2212020-52-3 / Hemicalcium Salt CAS: 2415797-61-2) is manufactured via organic small-molecule chemical synthesis rather than biological fermentation, European pharmaceutical giants, UK clinical innovators, and contract manufacturing organizations (CDMOs) across Ireland, Germany, the UK, and Switzerland require metric-ton capacity for its chiral indole building blocks and Evans chiral auxiliaries.

At Lifechem Pharma (lifechempharma.com), we manufacture and supply the complete series of essential starting materials, chiral cyclic sulfates, and enantiopure Evans oxazolidinone auxiliaries with guaranteed stereochemical purity (ee > 99.5%) for commercial Orforglipron production in Europe and the UK.

Lifechem Pharma’s Orforglipron Intermediates Portfolio

We manufacture and export the following 5 critical building blocks and chiral auxiliaries to European and UK CDMO facilities:

Technical Breakdown & Role in Stereoselective Synthesis

2. 5-Bromo-1H-indole-2-carboxylic acid (CAS: 7254-19-5) — Indole Core

• Chemical Identifiers: Molecular Formula: C9H6BrNO2 | Molecular Weight: 240.05 g/mol
• Synthetic Role: The foundational indole core. The C5-bromo position serves as the reactive handle for palladium-catalyzed cross-coupling and conjugate addition to construct the core tetrahydropyranyl-indole intermediate (CAS: 2212021-83-3).
• Lifechem Export Spec: Purity >= 99.0% by HPLC, Single Impurity <= 0.3%, Loss on Drying < 0.5%, off-white to beige crystalline solid.

2. (R)-4-Methyl-1,3,2-dioxathiolane 2,2-dioxide (CAS: 1006381-03-8) — Chiral Sulfate

• Chemical Identifiers: Molecular Formula: C3H6O4S | Molecular Weight: 138.14 g/mol
• Synthetic Role: An enantiopure chiral cyclic sulfate reagent used for stereospecific nucleophilic alkylation with complete inversion of configuration, installing chiral methyl-branched side chains without racemization.
• Lifechem Export Spec: Purity >= 98.5% by GC, Optical Purity ee > 99.0%, low moisture (< 0.2%), sealed under inert gas.

3. (R)-4-Benzyl-2-oxazolidinone (CAS: 102029-44-7) — Primary Evans Auxiliary

• Chemical Identifiers: Molecular Formula: C10H11NO2 | Molecular Weight: 177.20 g/mol
• Synthetic Role: Industry-standard Evans auxiliary utilized in copper-catalyzed asymmetric 1,4-conjugate addition to establish single enantiomeric stereocenters in the tetrahydropyranyl fragment with >99.5% chiral induction.
• Lifechem Export Spec: Purity >= 99.0% by HPLC, Specific Optical Rotation [a]D20 = +59° to +63° (c=1, ethanol), white crystalline solid.

4. (R)/(S)-4-Phenyl-2-oxazolidinone (CAS: 90319-52-1 / 99395-88-7) — Auxiliary Alternatives

• Chemical Identifiers: Molecular Formula: C9H9NO2 | Molecular Weight: 163.17 g/mol
• Synthetic Role: Complementary Evans auxiliaries offering steric differentiation for alternative chiral enolate alkylations and stereochemical resolution in custom Orforglipron synthesis pathways.
• Lifechem Export Spec: Purity >= 99.0% by HPLC, Enantiomeric Excess ee > 99.5%, heavy metals < 10 ppm.

Meeting European CDMO Quality & Compliance Demands

European and UK CDMOs operating in high-volume metabolic therapies require guaranteed batch consistency and full traceability:

• Stereochemical Assurance: Chiral HPLC and optical polarimetry data provided with every auxiliary batch, ensuring finished Orforglipron active substance achieves enantiomeric excess > 99.0%.
• REACH & ASMF Support: Complete Route of Synthesis (ROS) and REACH compliance data to support ASMF (Active Substance Master File) compilation for European health authorities.
• Elemental Impurity Control: Screened for residual heavy metals (Pd, Cu, Ni by ICP-MS) under ICH Q3D to ensure compliance with European Pharmacopoeia standards.

Supply Chain Security for European Oral GLP-1 Scaling

With European manufacturing sites (including Eli Lilly’s facility expansion in Katwijk, Netherlands and Novo Nordisk in Athlone, Ireland) scaling up oral peptide and non-peptide capacities, Lifechem Pharma provides dependable dual-sourcing capabilities:

• European Air Cargo: Rapid air cargo dispatch to London Heathrow (LHR), Frankfurt (FRA), Dublin (DUB), and Amsterdam (AMS) with complete customs clearing documentation.
• Moisture-Proof Packaging: UN-approved fiber drums with multi-barrier barrier liners and moisture indicators for cyclic sulfates and moisture-sensitive reagents.

Frequently Asked Questions for European Sourcing Leads

Q1: Does Lifechem Pharma supply Orforglipron intermediates to the UK and European Union?

Yes. Lifechem Pharma regularly supplies 5-Bromo-1H-indole-2-carboxylic acid (CAS: 7254-19-5), (R)-4-Methyl-1,3,2-dioxathiolane 2,2-dioxide (CAS: 1006381-03-8), and Evans chiral auxiliaries directly to pharmaceutical firms and CDMOs in the UK, Germany, Ireland, Switzerland, and France.

Q2: What is the optical purity guarantee on your Evans chiral auxiliaries?

Our (R)-4-Benzyl-2-oxazolidinone (CAS: 102029-44-7) and 4-Phenyl-2-oxazolidinones guarantee optical purity and enantiomeric excess (ee) > 99.5%, fully verified by chiral HPLC and polarimetric analysis.

Q3: Does Lifechem Pharma manufacture finished Orforglipron dosage tablets?

No. Lifechem Pharma is an intermediate and chiral building block manufacturer only. We supply chemical precursors to licensed pharmaceutical developers and contract manufacturers.

Request a European Quotation & Technical Dossier

Secure dependable, metric-ton-scale supply of Orforglipron starting materials and Evans chiral auxiliaries for your European development and commercial pipelines.